SEP 1, 2026 · REVIEW
Prevalence and Study-Level Predictors of Chronic Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis
Journal of Pain Research
Systematic review and meta-analysis of 197 studies with 72,794 patients providing a pooled prevalence estimate with confidence interval; rigorous methodology but epidemiological rather than intervention-based evidence.
Reported
Global prevalence of chronic CIPN44.50% (95% CI 40.77–48.25%)
Prevalence at 3–12 months post-ch…54.37% (95% CI 48.24–60.45%)
Prevalence at 12–24 months post-c…37.12% (95% CI 30.15–44.26%)